These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25180281)

  • 41. Gender and injuries predict stimulant medication use.
    Dalsgaard S; Leckman JF; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):253-9. PubMed ID: 24813570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
    Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
    Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
    Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
    Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
    J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations between Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Patient Nutritional Status and Height.
    Granato MF; Ferraro AA; Lellis DM; Casella EB
    Behav Neurol; 2018; 2018():7341529. PubMed ID: 30386441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study.
    Chien IC; Lin CH; Chou YJ; Chou P
    Soc Psychiatry Psychiatr Epidemiol; 2012 Dec; 47(12):1885-90. PubMed ID: 22476209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
    Harty SC; Ivanov I; Newcorn JH; Halperin JM
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):331-9. PubMed ID: 21823914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ
    J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
    CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.
    Waxmonsky JG; Pelham WE; Campa A; Waschbusch DA; Li T; Marshall R; Babocsai L; Humphery H; Gnagy E; Swanson J; Hanć T; Fallahazad N; Pelham WE
    J Am Acad Child Adolesc Psychiatry; 2020 Dec; 59(12):1330-1341. PubMed ID: 31473291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth dysregulation and ADHD: an epidemiologic study of children in France.
    Faraone SV; Lecendreux M; Konofal E
    J Atten Disord; 2012 Oct; 16(7):572-8. PubMed ID: 21817155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; Werner KS; McCabe VV; Veliz PT
    Psychiatr Serv; 2024 Jul; 75(7):622-629. PubMed ID: 38321920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential effects of attention deficit hyperactivity disorder medication on body height and body weight in a longitudinal pediatric cohort study, the LIFE Child study.
    Herzig M; Klaus VC; Bertsche A; Hilbert C; Kiess W; Bertsche T; Neininger MP
    Pharmazie; 2024 Oct; 79(9):202-208. PubMed ID: 39407424
    [No Abstract]   [Full Text] [Related]  

  • 57. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
    Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
    Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S; Kvist AP; Leckman JF; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):302-10. PubMed ID: 24956171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.